David J. Jacofsky, MD
Chairman of the Board
David J. Jacofsky, MD is an international speaker and respected authority in complex adult joint reconstruction and oncology, and is a leading authority on health care reform strategies. Dr. Jacofsky has extensive background in business management. He is the founder, CEO and Chairman of Healthcare Outcomes Performance Co. (HOPCo) and The CORE Institute®, and its affiliated entities. He is the Chairman of The Board for Cold Plasma Medical Technologies and has been the CEO of multiple successful start-up companies.Read Full Bio
Alan Hoops has more than 30 years of experience in the healthcare and managed care industries. Mr. Hoops was a former Chairman and CEO of PacifiCare (NYSE: PHS). Mr. Hoops jointed PacifiCare in 1977 and later led the rapid expansion of the Company during the 1990s. He assumed the role of CEO in April 1993 and became PacifiCare's Chairman of the Board in 1999.
During Mr. Hoops’ tenure as CEO, PacifiCare more than quadrupled revenues to $11 billion. Mr. Hoops presided over multiple acquisitions and organic growth that expanded PacifiCare from its California base to include health plan operations in eight western states. Notably, PacifiCare also launched the Secure Horizon's program which became the nation's largest Medicare HMO health plan, serving more than 1 million Medicare beneficiaries in nine statesRead Full Bio
David Floyd is a global medical technology leader serving as a corporate director and advisor, following 32-year career as a medical device industry executive. Substantial Board experience in both public and private companies, with a focus on governance, strategy development, commercialization, and M&A. Current NACD Governance Fellow, and Director and Chair, Nominating & Governance Committee for NN Inc., a NASDAQ-traded diversified industrial company. During career as a full-time operating executive, successfully led medical device businesses ranging from a pre-revenue start-up to a multi-divisional corporate group with over $5 billion in revenue. Developed transformational strategies, facilitated organizational alignment and drove initiatives that delivered accelerated top line growth and robust operating results. Broad experience in leading large, complex businesses, turnarounds, M&A and post-merger integration, and resolving significant regulatory and legal challenges. Known for being objective and fact-based, and recruiting and building strong management teams and winning cultures.Read More
Michael Fiore is an Operating Partner with Linden Capital Partners. He serves as an Advisor to the firm on opportunities in physician services, patient care delivery models, and value based care initiatives. Previously he served in Chief Executive Officer positions with several healthcare entrepreneurial ventures, including the most recent, Vantage Oncology, which he co-founded in 2002 and served as Chairman and Chief Executive Officer until its sale to McKesson Corporation in 2016.
Mr. Fiore has also served on multiple other Boards before their sale, including Cadent (sold to Invisalign) , Titan Health Corporation (sold to USPI), Pacific Dental Benefits (sold to United Healthcare) and California Cryobank (sold to GI Partners). In addition to HOPCO, he also currently serves on the Board of IVX Health, Gelmetix and Stability Health. He has an MBA from Harvard Business School, an MS Degree in Accounting from New York University, and a BA from Amherst College.
Nathan Every, MD
A cardiologist by training, Dr. Every has been with Frazier Healthcare Partners since 1999. He has led or co-led exited investments including Biostent (acquired by Abbott), Calibra Medical (acquired by LifeSpan), Rigel Pharmaceuticals (NASDAQ: RIGL), Flowcardia (acquired by C.R. Bard), BARRX, (acquired by Covidien), Ascension Orthopedics (acquired by Integra Lifesciences), Zeltiq (NASDAQ: ZLTQ), Glaukos (NASDAQ: GKOS), Packaging Coordinators Inc. (acquired by The Partners Group) and Abode Healthcare (acquired by Tailwind Capital). He currently serves on the boards of Correct Care Solutions, United Derm Partners, Silvergate Pharma, PCI, Leiter’s Compounding Pharmacy, The CORE Institute, and Vein Clinics of America. He also serves on the PRI Investment Committee for the Bill and Melinda Gates Foundation.
Adam is a Managing Director for Audax Private Equity, based in Boston. Adam joined Audax in 2000 and focuses on healthcare investing. Prior to joining Audax, Adam was with the private equity firm Thomas H. Lee Partners, where he completed buyouts across a number of industries. He also previously worked at Morgan Stanley & Co in its real estate principal investment group.
Adam received his A.B. from Harvard College.
Tim is a Managing Director for Audax Private Equity, based in Boston. Prior to joining Audax in 2008, Tim worked as an Associate at L.E.K. Consulting.
Tim received his A.B. from Duke University.